Clinical Trial Update: Mass Balance Study of MT-1303 [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 mass balance study of MT-1303 in relapsing-remitting multiple sclerosis. The trial was sponsored by Tanabe Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• MT-1303

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 1 | Status: COMPLETED